Gotham Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-40,560
| Closed | -$542K | – | 1438 |
|
2024
Q2 | $542K | Buy |
40,560
+39,138
| +2,752% | +$523K | 0.01% | 1069 |
|
2024
Q1 | $66K | Sell |
1,422
-32,351
| -96% | -$1.5M | ﹤0.01% | 1347 |
|
2023
Q4 | $2.28M | Sell |
33,773
-14,719
| -30% | -$995K | 0.04% | 560 |
|
2023
Q3 | $3.51M | Buy |
48,492
+9,797
| +25% | +$709K | 0.07% | 386 |
|
2023
Q2 | $2.88M | Buy |
38,695
+29,925
| +341% | +$2.23M | 0.06% | 437 |
|
2023
Q1 | $467K | Sell |
8,770
-16,234
| -65% | -$864K | 0.01% | 991 |
|
2022
Q4 | $1.69M | Sell |
25,004
-1,180
| -5% | -$79.8K | 0.05% | 481 |
|
2022
Q3 | $3.27M | Buy |
26,184
+7,141
| +37% | +$891K | 0.1% | 243 |
|
2022
Q2 | $1.81M | Buy |
19,043
+18,595
| +4,151% | +$1.77M | 0.06% | 402 |
|
2022
Q1 | $72K | Buy |
+448
| New | +$72K | ﹤0.01% | 1109 |
|